17-17219104-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_144997.7(FLCN):​c.977C>A​(p.Pro326Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P326L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)

Consequence

FLCN
NM_144997.7 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.50

Publications

0 publications found
Variant links:
Genes affected
FLCN (HGNC:27310): (folliculin) This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
FLCN Gene-Disease associations (from GenCC):
  • Birt-Hogg-Dube syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Birt-Hogg-Dube syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
  • familial spontaneous pneumothorax
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • renal carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • colorectal cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1648961).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLCNNM_144997.7 linkc.977C>A p.Pro326Gln missense_variant Exon 9 of 14 ENST00000285071.9 NP_659434.2 Q8NFG4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLCNENST00000285071.9 linkc.977C>A p.Pro326Gln missense_variant Exon 9 of 14 1 NM_144997.7 ENSP00000285071.4 Q8NFG4-1
ENSG00000264187ENST00000427497.3 linkn.149-50C>A intron_variant Intron 4 of 11 1 ENSP00000394249.3 J3QW42
FLCNENST00000577591.1 linkn.-1C>A upstream_gene_variant 2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Birt-Hogg-Dube syndrome Uncertain:1
Apr 28, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. This variant has not been reported in the literature in individuals affected with FLCN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 326 of the FLCN protein (p.Pro326Gln). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.060
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
10
DANN
Benign
0.52
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.46
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.41
T
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.16
T
MetaSVM
Uncertain
-0.027
T
MutationAssessor
Benign
1.4
L
PhyloP100
2.5
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.15
N
REVEL
Benign
0.17
Sift
Benign
0.35
T
Sift4G
Benign
0.18
T
Polyphen
0.20
B
Vest4
0.28
MutPred
0.27
Loss of glycosylation at P326 (P = 0.0591);
MVP
0.20
MPC
0.44
ClinPred
0.35
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.031
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138031155; hg19: chr17-17122418; COSMIC: COSV53257583; COSMIC: COSV53257583; API